Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.

Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.

Nordic Naturals now is offering Pro EPA Elite, a powerful EPA-only concentrate available without a prescription, the company stated.

BeKoool, makers of a cooling soft gel sheet formulated for children to relieve fevers, announced a new product to relieve itching and scratching associated with insect bites, poison ivy and more.

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

Teva Health Systems has launched a generic injectable drug for small-cell lung cancer, the company said.

A biotech company and a non-profit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.

The Food and Drug Administration has approved a new drug made by Merck for treating high cholesterol, the drug maker said.

Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.